Updated clinical classification of pulmonary hypertension ,
, Turk Kardiyol Dern Ars, vol.42, issue.1, pp.45-54, 2014.
Modern age pathology of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, pp.261-272, 2012. ,
Pulmonary vascular remodeling in pulmonary hypertension, Cell Tissue Res, vol.367, pp.643-649, 2017. ,
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Am J Pathol, vol.144, pp.275-285, 1994. ,
Pulmonary arterial hypertension: new pathophysiological insights and emerging therapeutic targets, Int J Biochem Cell Biol, vol.104, pp.9-13, 2018. ,
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape, Grover Conference Series). Pulm Circ, vol.8, p.2045893217752912, 2017. ,
Pulmonary vasodilators, Respir Care, vol.52, pp.885-899, 2007. ,
Treatment of pulmonary arterial hypertension, N Engl J Med, vol.351, pp.1425-1436, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01455600
Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension, Am J Cardiol, vol.108, pp.460-464, 2011. ,
Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the nationwide inpatient sample database from, JAMA Cardiol, vol.1, pp.1021-1029, 2001. ,
Role for Runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.194, pp.1273-1285, 2016. ,
Implication of inflammation and epigenetic readers in coronary artery remodeling in patients with pulmonary arterial hypertension, Arterioscler Thromb Vasc Biol, vol.37, pp.1513-1523, 2017. ,
Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.200, pp.910-920, 2019. ,
The resting perfusion pattern associates with functional decline in type 2 diabetes, Neurobiol Aging, vol.60, pp.192-202, 2017. ,
Compromised cerebrovascular regulation and cerebral oxygenation in pulmonary arterial hypertension, J Am Heart Assoc, vol.6, p.6126, 2017. ,
Cerebral microvascular blood flow and CO 2 reactivity in pulmonary arterial hypertension, Respir Physiol Neurobiol, vol.233, pp.60-65, 2016. ,
Sleep disordered breathing in group 1 pulmonary arterial hypertension, J Clin Sleep Med, vol.10, pp.277-283, 2014. ,
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension, Chest, vol.128, issue.6, p.617, 2005. ,
Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension, J Rheumatol, vol.36, pp.970-975, 2009. ,
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost, Am Heart J, vol.153, pp.1-7, 2007. ,
The link between chronic kidney disease and cardiovascular disease, J Nephropathol, vol.3, pp.99-104, 2014. ,
Cardio-pulmonary-renal interactions: a multidisciplinary approach, J Am Coll Cardiol, vol.65, pp.2433-2448, 2015. ,
Kidney dysfunction in patients with pulmonary arterial hypertension, Pulm Circ, vol.7, pp.38-54, 2017. ,
Pulmonary hypertension and chronic kidney disease: invasive hemodynamic etiology and outcomes in a large electronic medical recordbased cohort ,
, J Am Coll Cardiol, vol.67, issue.13, p.2048, 2016.
Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, vol.173, pp.1023-1030, 2006. ,
Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension, Circulation, vol.117, pp.2475-2483, 2008. ,
Albuminuria reflects widespread vascular damage: the Steno hypothesis, Diabetologia, vol.32, pp.219-226, 1989. ,
Iwate-Kenco Study Group. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals, J Hypertens, vol.34, p.512, 2016. ,
Lowgrade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study, Circulation, vol.112, pp.969-975, 2005. ,
Low-grade albuminuria in pulmonary arterial hypertension, Pulm Circ, vol.9, p.2045894018824564, 2019. ,
Retinopathy signs improved prediction and reclassification of cardiovascular disease risk in diabetes: a prospective cohort study, Sci Rep, vol.7, p.41492, 2017. ,
Bilaterally dilated episcleral vessels in patients with heritable pulmonary arterial hypertension, J Gen Fam Med, vol.18, pp.464-465, 2017. ,
Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies, Pulm Circ, vol.9, p.2045894018819781, 2018. ,
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study, Rheumatology (Oxford), vol.52, pp.1525-1528, 2013. ,
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension, Microvasc Res, vol.114, pp.46-51, 2017. ,
Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis, Ann Rheum Dis, vol.68, pp.191-195, 2009. ,
Sublingual microcirculation in pulmonary arterial hypertension, Ann Am Thorac Soc, vol.11, pp.504-512, 2014. ,
Association between BMI and obesity with survival in pulmonary arterial hypertension, Chest, vol.154, pp.872-881, 2018. ,
Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension, Pulm Circ, vol.4, pp.311-318, 2014. ,
Insulin resistance in pulmonary arterial hypertension, Eur Respir J, vol.33, pp.318-324, 2009. ,
A potential role for insulin resistance in experimental pulmonary hypertension, Eur Respir J, vol.41, pp.861-871, 2013. ,
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-g activation, Circulation, vol.115, pp.1275-1284, 2007. ,
PPARg agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation, Sci Transl Med, vol.10, p.303, 2018. ,
Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation, Diabetes, vol.50, pp.1771-1777, 2001. ,
Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension, Circulation, vol.133, pp.1936-1944, 2016. ,
Human PAH is characterized by a pattern of lipid-related insulin resistance, JCI Insight, vol.4, p.123611, 2019. ,
Pulmonary hypertension in thyroid diseases, Endocrine, vol.54, pp.578-587, 2016. ,
Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study, J Clin Endocrinol Metab, vol.92, pp.1736-1742, 2007. ,
Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure, Cardiovasc Ultrasound, vol.6, p.29, 2008. ,
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry, Chest, vol.137, pp.376-387, 2010. ,
Pulmonary hypertension and thyroid disease, Chest, vol.132, pp.793-797, 2007. ,
Hypothyroidism and the heart, Methodist DeBakey Cardiovasc J, vol.13, pp.55-59, 2017. ,
The prognostic impact of thyroid function in pulmonary hypertension, J Heart Lung Transplant, vol.35, pp.1427-1434, 2016. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, p.1801913, 2019. ,
The metabolic syndrome: role of skeletal muscle metabolism, Ann Med, vol.38, pp.389-402, 2006. ,
Effects of dipyridamole on muscle blood flow in exercising miniature swine, Am J Physiol, vol.257, pp.1507-1515, 1989. ,
Oxygen cost of exercise hyperpnea: implications for performance, J Appl Physiol, vol.72, pp.1818-1825, 1985. ,
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension, Eur Respir J, vol.44, pp.704-713, 2014. ,
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension, Eur Respir J, vol.32, pp.393-398, 2008. ,
Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension, Respir Med, vol.101, pp.2366-2369, 2007. ,
Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension, Thorax, vol.65, pp.113-117, 2010. ,
Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension, J Mol Med (Berl), vol.93, pp.573-584, 2015. ,
Skeletal muscle abnormalities in pulmonary arterial hypertension, PLoS One, vol.9, p.114101, 2014. ,
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.190, pp.318-328, 2014. ,
Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.25, pp.125-130, 2005. ,
Diaphragm muscle fiber weakness in pulmonary hypertension, Am J Respir Crit Care Med, vol.183, pp.1411-1418, 2011. ,
Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension, Med Sci Sports Exerc, vol.47, pp.2273-2282, 2015. ,
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension, Eur Respir J, vol.45, pp.1737-1740, 2015. ,
Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study, Respir Care, vol.58, pp.2134-2141, 2013. ,
Effects of exercise and vasodilators on cerebral tissue oxygenation in pulmonary hypertension, Lung, vol.193, pp.113-120, 2015. ,
Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study, Pulm Circ, vol.8, p.2045894018768290, 2018. ,
The effect of ageing and immobilization on structure and function of human skeletal muscle fibres, J Physiol, vol.552, pp.499-511, 2003. ,
Assessment of daily life physical activities in pulmonary arterial hypertension, PLoS One, vol.6, p.27993, 2011. ,
Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease, Int J Cardiol, vol.168, pp.375-381, 2013. ,
Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension, Chest, vol.143, pp.333-343, 2013. ,
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension, Circulation, vol.114, pp.1482-1489, 2006. ,
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension, Eur Respir J, vol.53, p.1800332, 2019. ,
The bronchial circulation: small, but a vital attribute of the lung, Am Rev Respir Dis, vol.135, pp.463-481, 1987. ,
The bronchial arteries in chronic obstructive pulmonary disease, Am J Med, vol.46, pp.506-515, 1969. ,
CT findings in diseases associated with pulmonary hypertension: a current review, Radiographics, vol.30, pp.1753-1777, 2010. ,
Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension, PLoS One, vol.8, p.78132, 2013. ,
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension, Eur Respir J, vol.48, pp.1668-1681, 2016. ,
Intrapulmonary bronchopulmonary anastomoses and plexiform lesions in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.193, pp.574-576, 2016. ,
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ Res, vol.115, pp.165-175, 2014. ,
Inflammation in pulmonary arterial hypertension, Chest, vol.141, pp.210-221, 2012. ,
Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension, Circ Res, vol.124, pp.904-919, 2019. ,
Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure, Eur Heart J, vol.37, pp.1684-1691, 2016. ,
Gut-lung connection in pulmonary arterial hypertension, Am J Respir Cell Mol Biol, vol.56, pp.402-405, 2017. ,
Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite, Nitric Oxide, vol.13, pp.272-278, 2005. ,
Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction, Am J Physiol Heart Circ Physiol, vol.296, pp.1281-1288, 2009. ,
Nitrite and nitrate-dependent generation of antiinflammatory fatty acid nitroalkenes, Free Radic Biol Med, vol.89, pp.333-341, 2015. ,